Optimal method for detecting cervical lymph node metastasis from papillary thyroid cancer.
[PURPOSE] Papillary thyroid cancer (PTC) is often accompanied by cervical lymph node metastases (LNM).
- p-value P = 0.005
- p-value P = 0.01
APA
Xiao J, Meng S, et al. (2023). Optimal method for detecting cervical lymph node metastasis from papillary thyroid cancer.. Endocrine, 79(2), 342-348. https://doi.org/10.1007/s12020-022-03213-6
MLA
Xiao J, et al.. "Optimal method for detecting cervical lymph node metastasis from papillary thyroid cancer.." Endocrine, vol. 79, no. 2, 2023, pp. 342-348.
PMID
36472754
Abstract
[PURPOSE] Papillary thyroid cancer (PTC) is often accompanied by cervical lymph node metastases (LNM). This study compared the diagnostic performance of fine needle aspiration (FNA), the combination of FNA and thyroglobulin measurement in the washout (FNA-Tg), and core needle biopsy(CNB) in order to determine the optimal method in detecting cervical LNM from PTC.
[METHODS] PTC patients with suspicious cervical lymph nodes, who underwent ultrasonography-guided FNA, or CNB before surgery were retrospectively reviewed between January 2021 and April 2022. Patients' demographics, lymph node size, and results of FNA, FNA-Tg, CNB and surgical pathology were collected. Sensitivitity, specificity, positive predictive value (PPV), negative predictive value (NPV), accuracy and the area under the curves (AUC) of receiver operating characteristic were obtained.
[RESULTS] FNA-Tg had a higher AUC with a threshold of 55 ng/mL than that with a threshold of 1 ng/mL (0.782 vs. 0.636, P = 0.005). The sensitivity of the combination of FNA and FNA-Tg was higher than that of FNA alone (91.3% vs. 81.0%, P = 0.01), but it was not different from that of CNB (91.3% vs. 88.0%, P > 0.05). No significant difference was found in specificity, PPV, NPV, accuracy and AUC among FNA alone, CNB alone, and the combination of FNA and FNA-Tg.
[CONCLUSIONS] FNA-Tg is useful to improve the sensitivity of FNA. The diagnostic performance of the combination of FNA and FNA-Tg is better than that of FNA or FNA-Tg alone, but is not different from that of CNB in detecting LNM from PTC.
[METHODS] PTC patients with suspicious cervical lymph nodes, who underwent ultrasonography-guided FNA, or CNB before surgery were retrospectively reviewed between January 2021 and April 2022. Patients' demographics, lymph node size, and results of FNA, FNA-Tg, CNB and surgical pathology were collected. Sensitivitity, specificity, positive predictive value (PPV), negative predictive value (NPV), accuracy and the area under the curves (AUC) of receiver operating characteristic were obtained.
[RESULTS] FNA-Tg had a higher AUC with a threshold of 55 ng/mL than that with a threshold of 1 ng/mL (0.782 vs. 0.636, P = 0.005). The sensitivity of the combination of FNA and FNA-Tg was higher than that of FNA alone (91.3% vs. 81.0%, P = 0.01), but it was not different from that of CNB (91.3% vs. 88.0%, P > 0.05). No significant difference was found in specificity, PPV, NPV, accuracy and AUC among FNA alone, CNB alone, and the combination of FNA and FNA-Tg.
[CONCLUSIONS] FNA-Tg is useful to improve the sensitivity of FNA. The diagnostic performance of the combination of FNA and FNA-Tg is better than that of FNA or FNA-Tg alone, but is not different from that of CNB in detecting LNM from PTC.
MeSH Terms
Humans; Thyroid Cancer, Papillary; Thyroid Neoplasms; Lymphatic Metastasis; Thyroglobulin; Retrospective Studies; Lymph Nodes; Sensitivity and Specificity
같은 제1저자의 인용 많은 논문 (5)
- Correlation study of nutritional status, mental health, sleep quality, and prognosis in patients with acute myeloid leukemia: Construction of early warning combined with mindfulness awareness countermeasures.
- Isoimperatorin inhibits cell proliferation and induces apoptosis via regulating PI3K/AKT pathway in acute lymphoblastic leukemia.
- Efficacy and safety of tepotinib in MET‑altered non‑small cell lung cancer: a meta-analysis.
- Clinical features, treatment, and outcomes of anti-PD-1/PD-L1 immune checkpoint inhibitors induced dermatomyositis.
- Clinicopathological characteristics and management of nivolumab/pembrolizumab-induced fasciitis in cancer patients.